|
PF-33569 |
HEMORAAS 200 UI Polvo para uso parenteral |
2009-08-11 |
|
Shanghai Raas Blood Products Co Ltd |
República de China
|
Norvanda Healthcare, S A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33572 |
PROTHORAAS Polvo para uso Parenteral |
2009-08-11 |
|
Shanghai Raas Blood Products Co Ltd |
República de China
|
Norvanda Healthcare, S A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33573 |
INMUNOGLOBULINA INTRAVENOSA HUMANA Shangai 5 % Solución inyectable |
2014-08-11 |
|
Shanghai Raas Blood Products Co Ltd |
República de China
|
Norvanda Healthcare, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33574 |
ALBURAAS 10 g/50mL Solucion Inyectable |
2009-08-11 |
|
Shanghai Raas Blood Products Co Ltd |
República de China
|
Norvanda Healthcare, S A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56473 |
XELODA 500 mg Comprimidos recubiertos |
2024-03-18 |
|
F. Hoffmann-La Roche, S.A. |
República de China
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-35589 |
SHANVAC-B, Suspension Inyectable |
2010-07-08 |
|
Shantha Biotechnics Ltd. |
India
|
Conamep |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-53525 |
SHAN-5 Suspensión inyectable |
2021-11-14 |
|
Shantha Biotechnics Private Limited. |
India
|
Sanofi-Aventis De Guatemala |
J.I.Cohen, S.A. |
Servicio De Comercio Internacional |
Droguería Y Farmacia Lanquetin |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48869 |
MEBO Ungüento tópico |
2018-07-16 |
|
Julphar (Gulf Pharmaceutical Industries) |
República de China
|
Novoswiss Pharmaceuticals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-50318 |
SALES DE REHIDRATACIÓN Oral Shanxi Polvo para solución oral 27.9 g sabor a naranja |
2024-07-14 |
|
Shanxi Federal Pharmaceutical Co. Ltd. |
República de China
|
Promegal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-50640 |
AMOXICILINA Shanxi 250 mg /5mL Polvo para suspensión oral. |
2024-09-22 |
|
Shanxi Federal Pharmaceutical Co. Ltd. |
República de China
|
Promegal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|